PreprintCited by 860SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSingle-cell and spatial transcriptomics

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2

Open access

Zhao, Yu, Zhao, Zixian, Wang, Yujia, Zhou, Yueqing, Ma, Yu, Zuo, Wei·2020·bioRxiv (Cold Spring Harbor Laboratory)

DOI 10.1101/2020.01.26.919985

Preprint — published as 10.1164/rccm.202001-0179le · Paper page

Open this paper in CoChat — free account Open PDF

Abstract

Abstract A novel coronavirus SARS-CoV-2 was identified in Wuhan, Hubei Province, China in December of 2019. According to WHO report, this new coronavirus has resulted in 76,392 confirmed infections and 2,348 deaths in China by 22 February, 2020, with additional patients being identified in a rapidly growing number internationally. SARS-CoV-2 was reported to share the same receptor, Angiotensin-converting enzyme 2 (ACE2), with SARS-CoV. Here based on the public database and the state-of-the-art single-cell RNA-Seq technique, we analyzed the ACE2 RNA expression profile in the normal human lungs. The result indicates that the ACE2 virus receptor expression is concentrated in a small population of type II alveolar cells (AT2). Surprisingly, we found that this population of ACE2-expressing AT2 also highly expressed many other genes that positively regulating viral entry, reproduction and transmission. This study provides a biological background for the epidemic investigation of the COVID-19, and could be informative for future anti-ACE2 therapeutic strategy development.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1101/2020.01.26.919985

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Self-citation
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020) · Science · doi:10.1126/science.abb2507 · Cited by 8,897
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676
Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission
Xu, X., Chen, P., Wang, J., Feng, J., Zhou, H., Li, X., Zhong, W., & Hao, P. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1637-5 · Cited by 2,202
Single-Cell Transcriptomic Analysis of Human Lung Provides Insights into the Pathobiology of Pulmonary Fibrosis
Reyfman, P. A., Walter, J. M., Joshi, N., Anekalla, K. R., McQuattie-Pimentel, A. C., Chiu, S., Fernandez, R., Akbarpour, M., Chen, C.-I., Ren, Z., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201712-2410oc · Cited by 1,203
Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes
Yang, J., Lin, S.-S., Ji, X.-J., & Guo, L.-M. (2009) · Acta Diabetologica · doi:10.1007/s00592-009-0109-4 · Cited by 1,117
Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion ConformationPreprint
Wrapp, D., Wang, N., Corbett, K. S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.11.944462 · Cited by 1,010
Addendum: A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2951-z · Cited by 715
Self-citation

Show all 20 references

Research works printed but not linked: 2

2020, Novel Wuhan (2019-nCoV) Coronavirus, American Journal of Respiratory and Critical Care Medicine, 201, P7
Zhao Y , Zhao ZX , Wang YJ , Zhou YQ , Ma Y , Zuo W. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. bioRxiv 2020.01.26.919985.

Sorted by citations

Items 501–600 of 850

New insights on possible vaccine development against SARS-CoV-2
Chaudhry, S. N., Hazafa, A., Mumtaz, M., Kalsoom, U., Abbas, S., Kainaat, A., Bilal, S., Zafar, N., Siddique, A., & Zafar, A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118421 · Cited by 10
Tropical Food Spices: A Promising Panacea for the Novel Coronavirus Disease (COVID‐19)
Ademiluyi, A. O., Oyeniran, O. H., & Oboh, G. (2020) · eFood · doi:10.2991/efood.k.201022.001 · Cited by 10
Neurological symptoms in COVID-19 patients
Altunışık, E., Sayıner, H. S., Aksöz, S., Çil, E., & Ozgenc, G. (2021) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2021_004 · Cited by 10
COVID-19 y su asociación con los inhibidores de la enzima convertidora de angiotensina y los antagonistas de los receptores para angiotensina II
(2020) · Revista de la Facultad de Medicina UNAM · doi:10.22201/fm.24484865e.2020.63.4.05 · Cited by 10
Enrichment of SARS-CoV-2 Entry Factors and Interacting Intracellular Genes in Tissue and Circulating Immune Cells
Devaprasad, A., & Pandit, A. (2021) · Viruses · doi:10.3390/v13091757 · Cited by 10
A review of metal nanoparticle‐based surface‐enhanced Raman scattering substrates for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) detection
Bakar, N. A., Yusoff, N. N., Azmi, F. S. N., & Shapter, J. G. (2023) · Aggregate · doi:10.1002/agt2.339 · Cited by 10
Aspectos y consideraciones generales en la enfermedad inflamatoria intestinal durante la pandemia por COVID-19
de Leon‐Rendón, J. L., Hurtado-Salazar, C., & Yamamoto-Furusho, J. K. (2020) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2020.05.001 · Cited by 10
Facts and Myths: Efficacies of Repurposing Chloroquine and Hydroxychloroquine for the Treatment of COVID-19
Al‐Bari, M. A. A. (2020) · Current Drug Targets · doi:10.2174/1389450121666200617133142 · Cited by 9
Lessons learned from the mechanisms of posttraumatic inflammation extrapolated to the inflammatory response in COVID-19: a review
Teuben, M. P. J., Pfeifer, R., Teuber, H., de Boer, L. L., Halvachizadeh, S., Shehu, A., & Pape, H. (2020) · Patient Safety in Surgery · doi:10.1186/s13037-020-00253-7 · Cited by 10
Severe Acute Respiratory Syndrome Coronavirus 2 and Male Reproduction: Relationship, Explanations, and Clinical Remedies
Jia, X., He, L., Zhang, Y., Hu, Z., Su, Y., Fang, Y., Peng, M., Fan, Z., Liu, C., Zhao, K., et al. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.651408 · Cited by 12
The impact of ACE2 genetic polymorphisms (rs2106809 and rs2074192) on gender susceptibility to COVID-19 infection and recovery: A systematic review
Suleiman, A. A., Rafaa, T. A., Al-Rawi, A. M., & Dawood, M. (2021) · Baghdad Journal of Biochemistry and Applied Biological Sciences · doi:10.47419/bjbabs.v2i03.53 · Cited by 10
The SARS-CoV-2 Spike mutation D614G increases entry fitness across a range of ACE2 levels, directly outcompetes the wild type, and is preferentially incorporated into trimersPreprint
Michaud, W. A., Boland, G. M., & Rabi, S. A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.25.267500 · Cited by 10
COVID-19 pada Kehamilan: Apakah berbahaya?
Ramadhani, H. S., Islamy, N., & Yonata, A. (2020) · Medical Profession Journal of Lampung · Cited by 9
A new parameter for predict the clinical outcome of patients with COVID‐19 pneumonia: The direct/total bilirubin ratio
Araç, S., & Özel, M. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14557 · Cited by 8
SARS-CoV-2–host cell surface interactions and potential antiviral therapies
Butnariu, A.-B., Look, A., Grillo, M., Tabish, T. A., McGarvey, M. J., & Pranjol, M. Z. I. (2021) · Interface Focus · doi:10.1098/rsfs.2020.0081 · Cited by 9
Post-COVID-19 and the Portuguese national eye care system challenge
Carneiro, V. L. A., Andrade, H., Matias, L. C., & Sousa, R. A. R. C. (2020) · Journal of Optometry · doi:10.1016/j.optom.2020.05.001 · Cited by 9
КОРОНАВІРУС 2019-nCOV: НОВІ ВИКЛИКИ ОХОРОНІ ЗДОРОВ’Я ТА ЛЮДСТВУ
Задорожна, В. І., & Vynnyk, N. P. (2020) · Інфекційні хвороби · doi:10.11603/1681-2727.2020.1.11091 · Cited by 9
Vitamin D deficiency as a factor for immunity stimulation and lower risk of acute respiratory infections and COVID-19
Каронова, Т. Л., Vashukova, M. A., Gusev, D. A., Golovatyuk, K. A., & Grineva, E. N. (2020) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2020-26-3-295-303 · Cited by 9
Local Bone Marrow Renin-Angiotensin System and COVID-19
Çiftçiler, R. (2020) · International Journal of Hematology and Oncology · doi:10.4999/uhod.204171 · Cited by 9
Structure, activity, and drug-likeness of pure compounds of Sumatran lichen (Stereocaulon halei) for the targeted ACE2 protein in COVID-19 disease
Putra, P. P., Abdullah, S. S., Rahmatunisa, R., Junaidin, J., & Ismed, F. (2020) · Pharmaciana · doi:10.12928/pharmaciana.v10i2.16877 · Cited by 9
Engineering mesenchymal stromal cells with neutralizing and anti-inflammatory capability against SARS-CoV-2 infection
Zhang, X., Han, P., Wang, H., Xu, Y., Li, F., Li, M., Fan, L., Zhang, H., Dai, Q., Lin, H., et al. (2021) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2021.05.004 · Cited by 9
Neurological manifestations in COVID-19 patients and their application in predicting fatal disease: A retrospective cohort study
Zhao, T., Zeng, H., Zhang, X., Chen, X., Jiang, W., Du, J., Liu, H., Zhao, J., Yuan, Y., Peng, X., et al. (2021) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2021.07.010 · Cited by 9
Host factors: Implications in immunopathogenesis of COVID-19
Jafarpour, R., Pashangzadeh, S., & Dowran, R. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153647 · Cited by 10
COVID-19 susceptibility and severity risks in a cross-sectional survey of over 500 000 US adults
Knight, S. C., McCurdy, S., Rhead, B., Coignet, M. V., Park, D. S., Roberts, G. H. L., Berkowitz, N., Zhang, M., Turissini, D. A., Delgado, K., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-049657 · Cited by 8
A Systematic Literature Review of Current Therapeutic Approaches for COVID-19 Patients
Soltani, S., Zakeri, A. M., Karimi, M. R., Rezayat, S. A., Anbaji, F. Z., Tabibzadeh, A., Yousefi, P., Zakeri, A., Jafarpour, A., Norouzi, M., et al. (2020) · Journal of Pharmaceutical Research International · doi:10.9734/jpri/2020/v32i730455 · Cited by 9
COVID-19 Incidence in Pakistan: Gender Disparity
Waris, A., Ali, M. U., Khan, A. U., Ali, A., Bangash, A. K., & Baset, A. (2020) · Iranian Journal of Psychiatry and Behavioral Sciences · doi:10.5812/ijpbs.105990 · Cited by 10
An insight into the inhibitory mechanism of phytochemicals and FDA-approved drugs on the ACE2–Spike complex of SARS-CoV-2 using computational methods
Jani, V., Koulgi, S., N, M. U. V., Sonavane, U., & Joshi, R. (2021) · Chemical Papers · doi:10.1007/s11696-021-01680-1 · Cited by 9
Possible Prevention of COVID 19 by Using Linoleic Acid (C18) Rich Algae OilPreprint
Subhash, V., Raja Krishna Kumar, G., Sapre, A. V., & Dasgupta, S. (2020) · doi:10.21467/preprints.36 · Cited by 9
Clinical features of critically ill patients with COVID-19 infection in ChinaPreprint
Hu, B., Wang, D., Hu, C., Hu, M., Zhu, F., Xiang, H., Zhao, B., Zhang, X., KASHANI, K. B., & Peng, Z. (2020) · doi:10.21203/rs.3.rs-16250/v1 · Cited by 9
The molecular basis of loss of smell in 2019-nCoV infected individualsPreprint
Gupta, K., Mohanty, S. K., Kalra, S., Mittal, A., Mishra, T., Ahuja, J., Sengupta, D., & Ahuja, G. (2020) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/cmfsp · Cited by 9
Risk factors for mortality among patients with SARS‐CoV‐2 infection: A longitudinal observational study
Almaghlouth, N. K., Davis, M. G., Davis, M. A., Anyiam, F. E., Guevara, R., & Antony, S. J. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26560 · Cited by 8
Threading the Pieces Together: Integrative Perspective on SARS-CoV-2
Kanakan, A., Mishra, N., Vasudevan, J. S., Sahni, S., Khan, A., Sharma, S., & Pandey, R. (2020) · Pathogens · doi:10.3390/pathogens9110912 · Cited by 8
Mutations in spike protein and allele variations in ACE2 impact targeted therapy strategies against SARS-CoV-2
Shu, C., 南京211166，中国, 南., Huang, X., Tang, H., Mo, D., Zhou, J., Deng, C., 210023，中国, 南. 南., 211166，中国, 南. 南., 211166，中国, 南. 南., et al. (2021) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2020.301 · Cited by 8
Binding of SARS-COV-2 (COVID-19) and SARS-COV to human ACE2: Identifying binding sites and consequences on ACE2 stiffness
Faisal, H. M. N., Katti, K. S., & Katti, D. R. (2021) · Chemical Physics · doi:10.1016/j.chemphys.2021.111353 · Cited by 9
Would carvacrol be a supporting treatment option effective in minimizing the deleterious effects of COVID-19?
de Carvalho, F. O., Silva, J. P. R., Silva, É. R., Júnior, R. L. C. D. A., Nunes, P. S., & Araújo, A. A. D. S. (2021) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-021-02170-7 · Cited by 8
RACCOVID-19: primer Registro Argentino de Complicaciones Cardiovasculares en pacientes con COVID-19
Kazelián, L. R., Zapata, G., Pereiro, S. M., Maydana, M., Lescano, A. J., Lorenzatti, A. J., & Estrada, J. L. N. (2021) · Revista Argentina de Cardiología · doi:10.7775/rac.es.v89.i4.20408 · Cited by 8
Vascular alterations among male elite athletes recovering from SARS-CoV-2 infection
Bauer, P., Kraushaar, L. E., Dörr, O., Keranov, S., NEF, H. M., Hamm, C. W., & Most, A. K. (2022) · Scientific Reports · doi:10.1038/s41598-022-12734-z · Cited by 8
Clinical management of lung cancer patients during the outbreak of COVID-19 epidemic
Wang, L., Jiang, M., Qu, J., Zhou, N., & Zhang, X. (2020) · Infectious Agents and Cancer · doi:10.1186/s13027-020-00322-7 · Cited by 8
COVID-19: advance in laboratory diagnostic strategy and technology
Yi, K., Rong, Y., Wang, C., Huang, L., & Wang, F. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-04004-1 · Cited by 8
Cytokine biomarkers of COVID-19Preprint
Deng, H., Long, Q., Liu, B., Ren, J., Liao, P., Qiu, J., Tang, X., Zhang, Y., Tang, N., Xu, Y., et al. (2020) · medRxiv · doi:10.1101/2020.05.31.20118315 · Cited by 8
The discovery of potential natural products for targeting SARS-CoV-2 spike protein by virtual screeningPreprint
Chen, G., Yao, T.-Y., Ahmed, A., Pan, Y., Yang, J., & Wu, Y. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.25.170639 · Cited by 8
BUNGA RAMPAI INTEGRASI KEILMUAN DALAM MENGHADAPI NEW NORMAL PADA MASA PANDEMI COVID-19Preprint
Yusuf, M. R. I. (2021) · doi:10.31219/osf.io/eq4k7 · Cited by 8
Diabetes mellitus and COVID-19. How are they connected? Current strategy of fight
Babenko, A. Y., & Laevskaya, M. Y. (2020) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2020-26-3-304-311 · Cited by 7
Clinical Properties and Diagnostic Methods of COVID‐19 Infection in Pregnancies: Meta‐Analysis
Uygun-Can, B., & Bolat, B. A. (2020) · BioMed Research International · doi:10.1155/2020/1708267 · Cited by 6
Vasculopathy in patients with severe COVID-19 infection
Beketova, T. V., & Nasonov, E. (2020) · Clinical Medicine (Russian Journal) · doi:10.30629/0023-2149-2020-98-5-325-333 · Cited by 8
Neurologic Manifestations of SARS-CoV-2, the Virus that Causes COVID-19
Naji, H. S. (2020) · European Journal of Medical and Health Sciences · doi:10.24018/ejmed.2020.2.6.533 · Cited by 7
Pharmacotherapy in Coronavirus Disease 2019 and Risk of Secondary Infections: A Single-Center Case Series and Narrative Review
Behal, M. L., Barlow, B., Mefford, B. M., Bastin, M. L. T., Donaldson, J. C., Laine, M. E., & Bissell, B. D. (2021) · Critical Care Explorations · doi:10.1097/cce.0000000000000492 · Cited by 7
Potential risk factors for case fatality rate of novel coronavirus (COVID-19) in China: A pooled analysis of individual patient data
Zhao, J., Li, X., Huang, W., & Zheng, J. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.08.039 · Cited by 9
Tissue Proteases and Immune Responses: Influencing Factors of COVID-19 Severity and Mortality
de Oliveira, N. M. T., Figueiredo, I. F. D. S., da Silva, L. C. M., da Silva, K. S., Bueno, L. R., da Luz, B. B., Corso, C. R., Werner, M. F. P., Fernandes, E. S., & Ferreira, D. M. (2020) · Pathogens · doi:10.3390/pathogens9100817 · Cited by 8
Role of ACE2 Gene Expression in Renin Angiotensin System and Its Importance in Covid-19: In Silico Approach
Taş, S. K., Kırkık, D., Işık, M. E., Kalkanli, N., Uzunoğlu, A. S., Uzunoğlu, M. S., Altunkanat, D., Alragabi, J. M. M., & Tanoğlu, A. (2020) · Brazilian Archives of Biology and Technology · doi:10.1590/1678-4324-2020200304 · Cited by 7
A retrospective analysis of the effect of the intervention of Arogya Kashayam in COVID-19 positive cases in Madhya Pradesh
Shukla, U., Srivastava, S., Gupta, P., & Ujjaliya, N. (2019) · AYU (An International Quarterly Journal of Research in Ayurveda) · doi:10.4103/ayu.ayu_365_20 · Cited by 7
Covid-19 Pandemi Mücadelesinde Kadıköy İlçe Sağlık Müdürlüğünün Organizasyonel Yapısı
Erdem, B., YILDIRIM, A. D., Erdem, F., Esencan, T. Y., & Neslihan, U. Y. A. R. (2021) · Turkish Journal of Family Medicine & Primary Care · doi:10.21763/tjfmpc.760179 · Cited by 7
Possible health benefits of polyphenols in neurological disorders associated with COVID-19
Oladele, J. O., Titilope, O., & Moses, O. (2020) · AFMN Biomedicine · doi:10.5937/afmnai38-30190 · Cited by 7
Functional Immune Deficiency Syndrome via Intestinal Infection in COVID-19Preprint
Prates, E. T., Garvin, M. R., Pavicic, M., Jones, P. C., Shah, M. B., Alvarez, C., Kainer, D., Demerdash, O., Amos, B. K., Geiger, A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.06.028712 · Cited by 7
Relação entre a miocardite e a infecção causada pelo SARS-CoV-2
Neto, J. C. P., da Silva, H. J. N., Souza, J. V. C., Cavalcante, K. F., Frazão, D. W. P., Soares, A. M., Garcia, A. C. H., Viana, D. D. N., Xavier, C., Furtado, D. R. L., et al. (2021) · Research Society and Development · doi:10.33448/rsd-v10i7.16357 · Cited by 6
Clinical Landmarks of COVID-19 in Newborn, Children and Teenagers
Bittmann, S., Luchter, E., Villalon, G., Moschüring-Alieva, E., & Weissenstein, A. (2020) · Journal of Pediatric Health and Nutrition · doi:10.14302/issn.2691-5014.jphn-20-3295 · Cited by 6
A Review on Coronavirus Disease 2019 (COVID-19) in Pediatric Patients
Moghadam, S. O., & Afshar, D. (2020) · Archives of Pediatric Infectious Diseases · doi:10.5812/pedinfect.104225 · Cited by 6
Anosmia in the course of COVID-19
Pissurno, N. S. C. A., Lichs, G. G. D. C., dos Santos, E. J. L., Druzian, A. F., de Oliveira, S. M. D. V. L., & Paniago, A. M. M. (2020) · Medicine · doi:10.1097/md.0000000000021280 · Cited by 6
COVID-19 Infection and Children: A Comprehensive Review
Mehrabani, S. (2020) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_277_20 · Cited by 6
Effect of COVID-19 On the Sexual Activity of Men
Abedinzadeh, M., Vahidi, S., Rahavian, A., Lojje, H., & Abouei, S. (2023) · American Journal of Men s Health · doi:10.1177/15579883231193913 · Cited by 6
Combating sars-cov-2 through lipoxins, proteasome, caveolin and nuclear factor-κb pathways in non-pregnant and pregnant populations
Çelik, Ö., Çelik, N., Aydın, S., Baysal, B., Aydın, S., Sağlam, A., Gursu, Y., Dalkılıç, S., Ulas, M., Özçil, M. D., et al. (2020) · Cellular and Molecular Biology · doi:10.14715/cmb/2020.66.3.36 · Cited by 6
Experience with the use of recombinant humanized monoclonal antibodies to the human receptor for interleukin-6 in patients with CoVID-19
Gusev, D. A., Vashukova, M. A., Павлович, Ф. И., Борисович, М. В., & Александрович, К. В. (2020) · Journal Infectology · doi:10.22625/2072-6732-2020-12-3-28-33 · Cited by 6
The Effects of Personal, Environmental, and Genetic Factors on Epidemic of Coronavirus Disease-19: A Review of the Current Literature
Bakhtiyari, S., Mirzaei, A., Jalilian, M., Mazloomi, S., Nourmoradi, H., & Kakaei, H. (2020) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2020.5098 · Cited by 6
Neurological Manifestations of SARS-CoV-2
Khan, A. R., Farooqui, M. O., Jatoi, N. N., Jawaid, S., Mahdi, D., & Khosa, F. (2020) · The Neurologist · doi:10.1097/nrl.0000000000000307 · Cited by 6
COVID-19 ölüm oranında etkili olan risk faktörlerinin Dematel yöntemi ile incelenmesi
Şen, G., DEMİREL, E., Selen, A. V. C. I., & Aladağ, Z. (2021) · Gazi Üniversitesi Mühendislik-Mimarlık Fakültesi Dergisi · doi:10.17341/gazimmfd.749133 · Cited by 6
Changes in Tobacco Use Patterns among Veterans in San Diego during the Recent Peak of the COVID-19 Pandemic
Fatollahi, J. J., Bentley, S., Doran, N., & Brody, A. L. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182211923 · Cited by 7
COVID-19 Pandemic as an Indicator of «Blank Spots» in Epidemiology and Infectious Pathology
Васильевич, С. М. (2020) · Journal of NBC Protection Corps · doi:10.35825/2587-5728-2020-4-3-338-373 · Cited by 6
Identifying patterns in COVID-19: Morbidity, recovery and the aftermath
Nikhra, V. (2020) · International Journal of Clinical Virology · doi:10.29328/journal.ijcv.1001016 · Cited by 6
Neurological Clinical Manifestations, Associated with COVID-19
Ai, F. (2020) · Неврология и нейрохирургия Восточная Европа · doi:10.34883/pi.2020.2.2.024 · Cited by 6
Single-cell analysis of human lung epithelia reveals concomitant expression of the SARS-CoV-2 receptor ACE2 with multiple virus receptors and scavengers in alveolar type II cellsPreprint
Han, G., Sinjab, A. F., Treekitkarnmongkol, W., Brennan, P. M., Hara, K., Chang, K., Bogatenkova, E., Sánchez‐Espiridión, B., Behrens, C., Gao, B., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.16.045617 · Cited by 8
Renin-Angiotensin-Aldosterone System: Double-Edged Sword in COVID-19 Infection
Burchfield, J. S. (2020) · Cited by 5
Bioinformatic evaluation of the potential animal models for studying SARS-Cov-2
Liu, B., Liu, S., Zhang, S., Bai, L., & Liu, E. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e05725 · Cited by 5
Lama Rawat Inap Pasien Terkonfirmasi COVID-19 di Rumah Sakit Universitas Indonesia dan Faktor yang Mempengaruhinya.
Fahmia, R., Helda, H., & Nursari, A. Y. (2022) · Jurnal Epidemiologi Kesehatan Indonesia · doi:10.7454/epidkes.v6i1.5004 · Cited by 5
Cytokine Storm Syndrome in COVID-19: Diagnosis and Management Strategies
Maggo, S., Dhull, P., & Dubey, A. P. (2020) · International Journal of Health Sciences and Research · Cited by 5
Could injured skin be a reservoir for SARS-CoV-2 virus spread?
Elgarhy, L. H., & Salem, M. L. (2020) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2020.06.004 · Cited by 5
Long-Term Prospects of Extrapulmonary Persistence of SARS-COV-2 Coronavirus
", Литвинов, А. С., LLP", M., L., U., Savin, A. V., & Kukhtina, A. A. (2020) · Medicina · doi:10.29234/2308-9113-2020-8-1-51-73 · Cited by 5
Tobacco and COVID-19
Sönmez, Ö., Taşdemir, Z. A., Kara, H., & Akçay, Ş. (2020) · Eurasian Journal of Pulmonology · doi:10.4103/ejop.ejop_52_20 · Cited by 5
Clinico-Demograhic Profile, Treatment Outline and Clinical Outcome of 236 Confirmed Hospitalized COVID- 19 Patients: A Multi-Centered Descriptive Study in Dhaka, Bangladesh
Islam, Q. T., Hossain, H., Fahim, F., & Rashid, M. (2020) · Bangladesh Journal of Medicine · doi:10.3329/bjm.v31i2.48532 · Cited by 5
Neurological Complications in COVID-19: Implications on International Health Security and Possible Interventions of Phytochemicals
Oladele, J. O., Oladele, O. T., Oyeleke, O. M., & Oladiji, A. T. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.96039 · Cited by 5
The Role of Bronchoscopy in the Diagnosis and Management of Patients with SARS-Cov-2 Infection
Biondini, D., Damin, M., Bonifazi, M., Cocconcelli, E., Semenzato, U., Spagnolo, P., Gasparini, S., Saetta, M. P., & Balestro, E. (2021) · Diagnostics · doi:10.3390/diagnostics11101938 · Cited by 6
Considerations in treating patients with advance lung cancer during the epidemic outbreak of novel coronavirus (SARS-CoV-2)
Cai, Y., Xu, Y., Xu, D., Wang, Y., Wang, X., Sun, C., Guo, Y., Qiu, S., & Ma, K. (2020) · Medical Oncology · doi:10.1007/s12032-020-01401-w · Cited by 5
Self-citation
Understanding COVID-19 Dispersion in the Filipino Sociocultural Context
Garcia, L., Castillo, J. M., Bejoc, J. A., Redula, E. H. E., Lapa, M. M. I. M., & Palompon, D. R. (2020) · Asia Pacific Journal of Health Management · doi:10.24083/apjhm.v15i3.467 · Cited by 5
Dynamic evaluation of lung involvement during coronavirus disease-2019 (COVID-19) with quantitative lung CT
Ma, C., Wang, X., Xie, D., Li, Y., Zheng, Y.-J., Zhang, H., & Ming, B. (2020) · Emergency Radiology · doi:10.1007/s10140-020-01856-4 · Cited by 5
Impact of medicinal plants on treatment of SARS-CoV, SARS-CoV-2 and influenza virus in India
Kolomi, M. L., Bharti, J., Kargo, M. A., & Bello, U. R. (2020) · Asian Journal of Pharmacy and Pharmacology · doi:10.31024/ajpp.2020.6.5.1 · Cited by 5
Para Infectious Guillain–Barre Syndrome (GBS) in Covid-19 – A Case Report
Lahole, S., Acharya, S., Raisinghani, N., Kumar, S., & Ghule, A. (2021) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2021/141 · Cited by 5
Coronavirus ORF1ab Polyprotein Associated Nsp16 Protein is a RlmE Methyltransferase and May Methylate 21S Mitochondrial rRNA of Most Mells Inhibiting Protein SynthesisPreprint
Chakraborty, A. K. (2020) · Preprints.org · doi:10.20944/preprints202004.0213.v1 · Cited by 5
The Pathophysiology of Virulence of the COVID-19Preprint
Soto, J. D., Hakim, S. T., & Boyd, F. (2020) · Preprints.org · doi:10.20944/preprints202004.0077.v2 · Cited by 4
Higher mortality in men from COVID19 infection-understanding the factors that drive the differences between the biological sexesPreprint
Iyer, S. P., Ensor, J., Anand, K., Hwu, P., Subbiah, V., Flowers, C. R., & Channappanavar, R. (2020) · medRxiv · doi:10.1101/2020.04.19.20062174 · Cited by 5
Mechanical Ventilation Stimulates Expression of ACE2, the Receptor for SARS-Cov-2Preprint
Huang, S., Kaipainen, A., Strasser, M., & Baranzini, S. E. (2020) · Preprints.org · doi:10.20944/preprints202005.0429.v1 · Cited by 5
ACE-2 in the highlight of COVID-19, A proposed pathology and potential correlationsPreprint
Sorour, K., Sarhan, H., & El-Menshawy, H. (2020) · doi:10.31730/osf.io/e7bk4 · Cited by 5
COVID-19 – A replay of the 1918 pandemic?
Sreekumar, G., Lohanathan, A., & Hazra, D. (2020) · Current Medical Issues · doi:10.4103/cmi.cmi_36_20 · Cited by 4
Evaluation of Angiotensin-converting Enzyme 2 (ACE2) in COVID-19: A Systematic Review on All Types of Studies for Epidemiologic, Diagnostic, and Therapeutic Purposes
Nemati, H., Ramezani, M., Najafi, F., Sayad, B., Nazeri, M., & Sadeghi, M. (2020) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2020.4763 · Cited by 4
Potential network markers and signaling pathways for B cells of COVID-19 based on single-cell condition-specific networks
Li, Y., Han, L., Li, P., Ge, J., Xue, Y., & Chen, L. (2023) · BMC Genomics · doi:10.1186/s12864-023-09719-1 · Cited by 4
Influência da suscetibilidade genética na incidência e mortalidade de COVID-19 (SARS-CoV-2)
Galisa, S. L. G., Almeida, R. M. D. S., Soares, A. R. A. P., Ribeiro, R. R. A., Pereira, F. R. A., Gomes, K. A. L., de Oliveira, M. E. C., Nóbrega, W. F. S., Andrade, L. S. D. S., Santos, T. T. D. M., et al. (2021) · Research Society and Development · doi:10.33448/rsd-v10i1.11812 · Cited by 4
Relationship Between COVID-19 and Angiotensin-Converting Enzyme 2: A Scoping Review
Asma, S., Vahedian‐Azimi, A., Faizi, F., Rahimi‐Bashar, F., Shahriary, A., Galeh, H. E. G., Nehrir, B., Guest, P. C., & Sahebkar, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-59261-5_5 · Cited by 4
Multidisciplinary Effort and Integrative Preparedness: A Lesson for the Foreseen Multivariate COVID-19 Pandemic Flare-Up
Yayehrad, A. T., Siraj, E. A., Yimenu, D. K., Ambaye, A. S., Derseh, M. T., Almaw, A., & Yayeh, T. G. (2021) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s332049 · Cited by 6
COVID-19-Associated Stroke
Щукин, И. А., Фидлер, М. С., Koltsov, I., & Suvorov, A. Y. (2022) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-022-01291-7 · Cited by 4
Exploring pathophysiology of COVID-19 infection: Faux espoir and dormant therapeutic options
Nikhra, V. (2020) · International Journal of Clinical Virology · doi:10.29328/journal.ijcv.1001013 · Cited by 4
Mysterious Side of COVID-19 Pandemic: Children
Arsoy, H. E. M., & Özdemır, Ö. (2020) · Istanbul Medical Journal · doi:10.4274/imj.galenos.2020.13463 · Cited by 4
COVID-19: Between Past and Present
Assaf, A. M., Haddadin, R. N., & Akour, A. A. (2020) · Viral Immunology · doi:10.1089/vim.2020.0102 · Cited by 4

Authors: Zhao, Y., Zhao, Z., Wang, Y., Zhou, Y., Ma, Y., & Zuo, W.
Affiliations: Tongji University (CN)
Regend Therapeutics (China) (CN)
Corresponding author: Zuo, Wei
Venue: bioRxiv (Cold Spring Harbor Laboratory)
Publisher: openRxiv
Published: 2020-01-26
DOI: 10.1101/2020.01.26.919985
OpenAlex: W3003154936
Cited by: 860
References: 20
Citations by year: 2026: 2 · 2025: 2 · 2024: 8 · 2023: 19 · 2022: 56 · 2021: 194 · 2020: 576
Type: posted content
Language: en
Open access: green
doi.org
Licence: www.biorxiv.org/about/FAQ#license (vor)
Locations: bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
Keywords: ACE2, SARS-CoV-2, COVID-19 pandemic, single-cell RNA sequencing, alveolar type II cells, lung tissue, viral receptor expression, SARS-CoV

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks